griseofulvin (Gris-Peg, Grifulvin V, Griseofulvin Ultramicrosize) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PREGNANCY: Griseofulvin is known to cause birth defects and should be avoided during pregnancy. Women of child bearing potential must use appropriate forms of contraception (birth control) during treatment and for one month after completing griseofulvin therapy. Men are advised to wait six months after completing griseofulvin therapy before attempting to father a child.

NURSING MOTHERS: It is not known whether griseofulvin is excreted into human milk. Due to the lack of conclusive safety data, the manufacturer recommends against the use of griseofulvin in nursing mothers.

REFERENCE: FDA Prescribing Information

Medically Reviewed by a Doctor on 10/14/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index

Health Solutions From Our Sponsors